Podcasts about regulatory

Join Tommy Shaughnessy as he sits down with Mike Dudas, Managing Partner at 6th Man Ventures, to discuss one of the most successful seed investments in crypto history. Mike shares the inside story of backing Pump.Fun years before it became a cultural phenomenon, generating over $800 million in fees and reaching a $5.5 billion FDV. From cold DMs to billion-dollar outcomes, this conversation explores venture capital strategy, founder evaluation, and navigating the intersection of AI and crypto investing.6th Man Ventures: https://6thman.ventures

This week we sit down with Suzanne Konstance, Vice-President and General Manager for Legal and Regulatory US at Wolters Kluwer. She outlines how the company supports professionals in highly regulated fields with software and authoritative content. Operations span multiple countries with a deliberately local approach, where teams design solutions for each market. Listeners get a clear view of scope, from enterprise legal management to recent additions such as Brightflag, alongside deep subject expertise.Konstance explains a core focus on regulatory compliance across securities, tax, IP, and employment. The aim is simple, help clients stay out of court. Continuous change drives editorial work, with authors and editors tracking shifts, executive orders, and practical effects. Provenance, version history, and context matter, supported by structured meta tagging which helps search and AI retrieve the right source every time.In a segment on trust, the conversation moves to standards for accuracy and auditability. Clients tell Wolters Kluwer quality outranks speed for research, so the team emphasizes authoritative sources and transparent sourcing. Konstance walks through a recent non-exclusive content license with Harvey for primary law from US and German collections, part of a broader collaboration strategy which also includes VitalLaw AI and new cross-border features. The goal is a reliable workflow where answers cite sources, show currency, and fit real practice.Real user labs reinforce these priorities. At AALL, librarians worked hands-on in a sandbox session with no guided prompts, pushing tools to limits and asking tough questions. One theme dominated, transparency, with live citations and source trails visible during use. Editors remain in the loop to curate likely questions, collect feedback, and refine outputs, while openness about progress helps teams separate market sizzle from dependable results.Looking ahead, Konstance expects roles to shift toward managing agents and setting clear instructions, similar to supervising a room full of interns, with strong expertise still required for oversight. Teams will need to train newcomers on fundamentals, auditing, and controls, so technology serves professionals, not the reverse. She also shares sources she follows, industry conversations with customers, conferences, LinkedIn, X, plus guidance from a long-standing internal Center of Excellence for AI. For more on Wolters Kluwer initiatives, listeners can visit wolterskluwer.com and explore the Legal and Regulatory section along with the AI hub.Also, check out Jerry David DeCicca and his new album, Cardiac Country.Links:Wolters Kluwer Legal & Regulatory U.S. page Wolters Kluwer's AI centerThe press release announcing the content licensing agreement with HarveyVitalLawListen on mobile platforms:  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ |  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠[Special Thanks to ⁠Legal Technology Hub⁠ for their sponsoring this episode.] Blue Sky: ⁠⁠@geeklawblog.com⁠⁠ ⁠⁠@marlgeb⁠⁠⁠⁠⁠⁠⁠Email: geekinreviewpodcast@gmail.comMusic: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Jerry David DeCicca⁠⁠⁠⁠⁠⁠⁠⁠⁠Transcript:

Healthcare compliance just shifted fundamentally.Traditional whistleblowers who needed inside access are being replaced by artificial intelligence (AI)-powered relators who mine public datasets and flag statistical anomalies that could signal fraud.The U.S. Department of Justice (DOJ) logged 979 qui tam cases in 2024, many of which were reportedly triggered by mathematical outliers, rather than insider tips. Government agencies, such as the Centers for Medicare & Medicaid Services (CMS), have already recovered $820 million using algorithmic detection.During the next live edition of Monitor Mondays, senior healthcare analyst Frank Cohen will reveal a possible solution for hospitals, health systems, and physician practices.The weekly broadcast will also include these instantly recognizable features:• Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.• The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.• Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.• Legislative Update: Adam Brenman, senior government affairs analyst for Zelis, will report on the news happening at the intersection of healthcare and congressional action.

Brandon Weichert highlights the immense power demands of AI and AGI data centers, requiring gigawatts of electricity and facing significant regulatory hurdles. He discusses the potential weaponization of AI, noting human nature's tendency to weaponize new technologies. Weichert shares personal experiences with AI tools like Grok, Gemini, and Claude, including instances of AI "diversion" rather than hallucination. He emphasizes the need to master this technology, as the substantial investment ensures its permanence. 1958

In this week's episode of This Week in AML, Elliot Berman and John Byrne unpack the latest regulatory developments. They begin with FinCEN Director Andrea Gacki's recent testimony before the House Financial Services Committee, highlighting key takeaways on beneficial ownership data, SAR/CTR streamlining, and real estate's role in money laundering. The conversation then shifts to new FinCEN guidance on geographically targeted MSB reporting and financially motivated sextortion. John and Elliot also dive into the OCC's controversial statements on SARs and debanking. On the international front, they explore new Wolfsberg Group guidance on stablecoin issuers, FATF's collaboration with Interpol, and Transparency International UK's push for beneficial ownership transparency in offshore financial centers.

Financial markets are some of the most heavily regulated markets in the United States. Firms and individuals that wish to engage in financial services–related businesses face complex regulatory regimes that are overseen by a web of agencies that includes, on the federal level, several banking regulators, two markets regulators, and a consumer protection regulator. But the regulation doesn't end there, as a host of other agencies, including state-level regulators and self-regulatory organizations, may also have oversight responsibilities. As attention has turned to ideas of government efficiency, financial regulation should not be left out of the conversation. But how should we right-size financial regulation?Our conference seeks to shed light on this question by asking: How many financial regulators is the right number? What should the balance be between federal and state financial regulation? Should the Federal Reserve shed its regulatory functions? Has federal intervention in housing finance gone too far?Join us at Cato's Center for Monetary and Financial Alternatives annual conference for an outstanding program featuring leading policymakers and experts discussing how to right-size financial regulation. Hosted on Acast. See acast.com/privacy for more information.

On this episode of Android Faithful with Jason Howell and Ron Richards, Beeper's new CEO Kishan Bagaria shares the app's evolution, the potential of AI integration, and a shift to on-device privacy. The conversation covers Beeper's fight against messaging silos, openness versus Apple's closed ecosystem, and plans to reach 100 million users.Note: Time codes subject to change depending on dynamic ad insertion by the distributor00:00 - Podcast begins04:54 - Introducing Kishan Bagaria, CEO of Beeper05:23 - Background and journey to Beeper CEO role07:11 - Experience since taking the CEO position07:41 - Overview of new Beeper tiers and features10:20 - User feedback on recent Beeper changes11:33 - Privacy and security shift to on-device connections14:44 - Beeper's approach to messaging interoperability17:20 - Regulatory landscape and Beeper's role in the US and EU19:46 - Matt Mullenweg's goal of 100 million users22:25 - Openness and open-source contribution as core values24:06 - Beeper integration with Clay personal CRM27:35 - Defining Beeper's core user base28:26 - What to expect from Beeper in 2026 including AI integrations30:06 - Closing remarks and future outlook Hosted on Acast. See acast.com/privacy for more information.

Senate Commerce Committee Chairman Ted Cruz said he would introduce legislation to establish AI sandboxes to allow companies “room to breathe” without running up against regulations. Cruz announced that proposal as well as a legislative framework for AI policy ahead of a Wednesday hearing before the Subcommittee on Science, Manufacturing, and Competitiveness on the administration's recent AI Action Plan. The concept of regulatory sandboxes were among the more than 90 policy recommendations outlined in that document. Cruz said during the hearing: “Under the Sandbox Act, an AI user developer can identify obstructive regulations and request a waiver or a modification, which the government may grant for two years via a written agreement that must include a participant's responsibility to mitigate health or consumer risks,” adding that “a regulatory sandbox is not a free pass. People creating or using AI still have to follow the same laws as everyone else.” Drew Myklegard is stepping down from his role as deputy federal CIO after nearly four years, FedScoop has learned. Two sources with knowledge of the matter said Myklegard told colleagues he's taking a role in the private sector and that his last day will be Sept. 22. A holdover from the Biden administration, Myklegard was appointed to the deputy federal CIO role in early 2022, after a more than eight-year stint in supporting IT operations at the Department of Veterans Affairs. During his time in the Office of the Federal CIO, he championed a number of key governmentwide technology modernization initiatives, including rolling out a new policy reforming federal cloud security authorizations under FedRAMP and guidance on how agencies acquire and inventory AI tools, among others. On Monday, Myklegard was recognized with a FedScoop 50 award in the Golden Gov: Federal Executive of the Year category. The Daily Scoop Podcast is available every Monday-Friday afternoon. If you want to hear more of the latest from Washington, subscribe to The Daily Scoop Podcast  on Apple Podcasts, Soundcloud, Spotify and YouTube.

Investors looking for a unique way to play the Trump administration's deregulatory push may want to consider the Free Markets ETF (FMKT). Michael Gayed discusses this first-of-its-kind ETF, which uses a combination of AI and human analysis to identify companies poised to benefit from regulatory shifts. He also shares his thoughts on the fund's market cap exposure and its approach to investing in digital assets like Bitcoin.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

Newt talks with Patrick McLaughlin, a research fellow at the Hoover Institution, where he leads the QuantGov analytics project focusing on regulations. McLaughlin discusses the growth of regulatory requirements from 400,000 restrictive terms in 1970 to 1.1 million today, highlighting the economic friction and opportunity costs associated with regulatory accumulation. He estimates that if regulations had been held constant since 1980, the U.S. economy could be 25% larger by 2012, equating to a $4 trillion increase. They also discuss the impact of the Supreme Court's decision to end Chevron deference, which previously allowed agencies to interpret statutes with significant discretion. Their conversation concludes with an examination of Virginia Governor Glenn Youngkin's successful regulatory reforms, which include a 25% reduction in regulatory inventory and the use of AI for cost-benefit analysis, setting a new standard for regulatory management.See omnystudio.com/listener for privacy information.

In this episode of Recycled Content, APR Technical Director Scott Trenor takes over hosting duties to explore the FDA's role in ensuring recycled plastics are safe for use in food packaging with guest Sean Fischer, an FDA Regulatory Review Scientist within the Division of Food Contact Substances. The two dive into the evaluation process, and critical need behind the FDA's No Objection Letters (NOL), an official statement from the FDA signaling that the agency has reviewed a recycling process and has no concerns about its ability to produce material suitable for food-contact use. The conversation also tackles common misconceptions, international alignment with Europe's EFSA, and how recyclers can better navigate regulatory pathways. Tune in to hear how recycled plastics move from curbside collection to safe, food-contact applications, and what it means for the future of circular packaging.

Digital Future Summit Series Episode 6: Trends in crypto, payments and fintechPresenters:Urszula McCormack, KWMJohn Ho, Standard Chartered BankShiau Sin Yen, Titan FundYvonne Tsui, Hong Kong Monetary AuthorityIn this episode of the Digital Future Summit Series, we explore the evolving landscape of digital finance in 2025. Our expert panel discusses the rapid advancements in crypto markets, stable coins, tokenisation, and regulatory frameworks across Asia and beyond. Join us for a deep dive into the key trends shaping the future of digital finance.Key points:The total crypto market cap has surged to approximately $3.5 trillion, with Bitcoin routinely trading over $100,000.Institutional adoption is accelerating, with significant interest in stable coins and tokenised assets for payments and fundraising.Regulatory clarity is emerging globally, fostering innovation and investor protection in sophisticated digital asset markets.Digital identity and interoperability are crucial for reducing friction and enhancing access to financial services.Asia is leading the charge in crypto adoption, driven by young tech-savvy populations and progressive regulatory frameworks.Additional Resources here:In Australia...Crypto custody: ASIC expands its Regulatory Guidance under RG 133 - KWMThe future of digital money is coming – evolutionary steps for Central Bank Digital Currency (CBDC) in AustraliaToken a closer look at the impact of digital asset cases on financial markets - KWMIn Hong Kong...Gen AI Guide for Financial InstitutionsHong Kong's new stablecoins law: what issuers and distributors need to knowHong Kong's Stablecoins Ordinance goes live today: What you need to know - KWMHong Kong Monetary Authority - Fintech Supervisory Sandbox (FSS)SFC Publishes Fresh Guidance for Virtual Asset Exchange Licensing - KWM

Digital Future Summit Series Episode 5: ASIC Chair Joe LongoPresenters:Alex Elser, KWMDavid Friedlander, KWMJoe Longo, ASIC ChairIn this episode of the Digital Future Summit series, ASIC Chair Joe Longo discusses the corporate regulator's discussion paper into private and public capital markets in Australia, considering the impact of AI, markets' operation, and the role of superannuation money. Longo shares insights from ASIC's recent paper and outlines the commission's approach to enhancing transparency and data collection in private markets.Key Points:ASIC's recent discussion paper aims to reshape public and private markets in Australia, emphasising the need for market transparency.Why Joe Longo believes the decline in public listings is influenced more by structural factors than regulatory burdens.Why ASIC seeks greater data visibility in private markets to enhance its understanding of capital flows and investment practices.How the commission is exploring the potential of digital financial reporting as a way to modernise market practices – and wider potential law reform.The importance of balancing regulation and innovation, particularly in the rapidly evolving AI landscape.Additional Resources here:https://download.asic.gov.au/media/44hh5ctv/australia-s-evolving-capital-markets-a-discussion-paper-on-the-dynamics-between-public-and-private-markets.pdfhttps://www.kwm.com/au/en/insights/latest-thinking/asics-private-markets-review-the-next-chapter.htmlhttps://www.asic.gov.au/about-asic/news-centre/inside-asic-podcast/#series2-episode2https://www.asic.gov.au/regulatory-resources/find-a-document/consultations/dp-australia-s-evolving-capital-markets-a-discussion-paper-on-the-dynamics-between-public-and-private-markets/#submissionshttps://www.asic.gov.au/about-asic/news-centre/find-a-media-release/2025-releases/25-096mr-asic-clears-path-for-faster-ipos/

In 2025, AI and automation are reshaping Asia's cybersecurity landscape, empowering both defenders and adversaries. CISOs face intelligent, self-evolving threats—from AI-generated deepfakes to autonomous malware—exploiting the region's rapid digitalisation and IT/OT convergence. While AI-driven SOAR and predictive analytics enhance response, over-reliance risks blind spots, especially with regionally biased data. Regulatory shifts in Japan, Singapore, India and beyond demand accountability in AI use, placing CISOs at the nexus of compliance and innovation. The rise of cross-border, AI-powered attacks underscores the need for resilient, adaptive security strategies. CISOs must balance automation with human oversight, secure generative AI platforms, and strengthen supply chain defences. Success hinges on anticipating threats, ensuring ethical AI deployment, and upskilling teams to operate effectively in an era of intelligent cyber conflict. The challenge is not just technical—but strategic, regional, and human.In this PodChats for FutureCISO, Kylie Watson, head of security at DXC Technology, shares her views on AI, automation and the next generation of threats.1.       Our topic is AI, automation and the next generation of threats. Please describe for us the relationship between all three as viewed from the perspective of a security professional.2.       How can CISOs ensure the integrity and security of third-party AI models integrated into their core business systems?3.       In your view, are incident response playbooks used by enterprises in Asia resilient enough to handle AI-powered, self-evolving malware?4.       What safeguards are in place to detect and prevent deepfake-driven social engineering attacks targeting regional executives?5.       How can enterprises maintain compliance with emerging AI governance regulations across multiple Asian jurisdictions?6.       To what extent are organisations auditing training data for bias, leakage, or adversarial manipulation in our automated systems?7.       Can current detection tools distinguish between legitimate automation and malicious AI-driven lateral movement?8.       How are enterprises preparing for supply chain attacks that exploit vulnerabilities in open-source AI frameworks?9.       Are security teams equipped with the skills to monitor, interpret, and challenge AI-driven security decisions?10.   How can enterprises build adaptive, intelligence-led defences that evolve in tandem with next-generation threats? What is the role of the CISO here?11.   Coming into 2026, how should CISOs and the security team prepare for the further deepening of the integration of AI into the organisational workflow?

Send me a text! I'd LOVE to hear your feedback on this episode!For all things Xylitol, go to https://xlear.com/Follow me on Instagram, where I am most active: https://www.instagram.com/sandyknutrition/I have 292 ratings, and I am honoured.  Please consider rating my podcast with a few kind words wherever you are listening.Follow me on Substack, where I write explorative short articles on wellness, body, mind, spirit & soul:  https://sandykruse.substack.com/Nate Jones, founder of Xlear, reveals how xylitol revolutionizes oral and nasal health by eliminating harmful bacteria and preventing pathogen adhesion to tissues. He shares compelling research about xylitol's effectiveness against respiratory infections, ear infections, and dental caries while explaining how it outperforms traditional treatments like fluoride.• Xylitol nasal spray was developed originally to prevent ear infections in children• Studies show xylitol prevents bacteria and viruses from adhering to tissue• Xylitol nasal spray increases airway volume by 36% compared to saline• Five-carbon sugars like xylitol were common in ancestral diets before refined sugar• Fluoride only masks tooth decay while xylitol treats the bacterial infection• Periodontal disease increased COVID hospitalization risk by 8x• Regulatory agencies prevented sharing of research about xylitol during pandemic• Grapefruit seed extract at 0.2% concentration showed remarkable antiviral properties• Proper hygiene and sanitation drove most health improvements historically, not pharmaceuticalsFind Xlear products at most major retailers including CVS, Walgreens, Target, Walmart, and natural health stores. Visit xlear.com for more information and research studies.Support the showPlease rate & review my podcast with a few kind words on Apple or Spotify. Subscribe wherever you listen, share this episode with a friend, and follow me below. This truly gives back & helps me keep bringing amazing guests & topics every week.Instagram: https://www.instagram.com/sandyknutrition/Facebook Page: https://www.facebook.com/sandyknutritionTikTok: https://www.tiktok.com/@sandyknutritionYouTube: https://www.youtube.com/channel/UCIh48ov-SgbSUXsVeLL2qAgRumble: https://rumble.com/c/c-5461001Linkedin: https://www.linkedin.com/in/sandyknutrition/Substack: https://sandykruse.substack.com/Podcast Website: https://sandykruse.ca

Consider this a wake-up call.As artificial intelligence (AI) quietly becomes part of the audit trail, healthcare leaders must ask a new question: who's reviewing the reviewers?During the next live edition of the venerable Monitor Mondays broadcast, contributing editor Sharon Easterling will break down why auditing AI tools are no longer a tech issue – they're a documentation integrity and compliance priority.Although this is an important topic for all healthcare professionals, register now to learn why it's particularly relevant for those in compliance and revenue integrity.The weekly broadcast will also include these instantly recognizable features:• Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.• The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.• Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.• Legislative Update: Cate Brantley, senior government affairs analyst for Zelis, will report on the news happening at the intersection of healthcare and congressional action.

The Myths of Biotech Investing Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. Biotech investing differs from tech investing. There's often no revenue traction to assess. The startup must navigate the FDA path while dealing with cutting-edge devices and therapeutics. Here are some myths of biotech investing: Myth 1-Biotech startups are building companies. In many cases, the biotech startup will sell during the clinical trials or at FDA approval. They rarely proceed to launching a business. Myth 2- Biotechs take much longer than tech companies to exit. Most biotech startups exit in the 3 to 5 year range, which is often shorter than tech companies. Myth 3- Regulatory is the key hurdle to overcome. In reality, it's proving the therapeutic works. Most drugs fail in clinical trials and never reach FDA submission. Myth 4-Reimbursement is the key to a successful biotech therapy. In reality, it's showing value to the physician and patient through high efficacy and low toxicity, which is the key to success. Consider these myths in analyzing biotech startups for investment.   Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding. Let's go startup something today. _______________________________________________________ For more episodes from Investor Connect, please visit the site at:   Check out our other podcasts here:   For Investors check out:   For Startups check out:   For eGuides check out:   For upcoming Events, check out    For Feedback please contact info@tencapital.group    Please , share, and leave a review. Music courtesy of .

In this episode, Chad Hughes welcomes Matteo Villani, President of 3 Peaks Land & Engagement Inc, to the show to explore the regulatory environment in British Columbia and the complexity of navigating the Indigenous communities, the environmental and regulatory needs, and the agricultural land reserve restrictions in order to access land for oil and gas assets. Matteo takes us through his twenty year career in the industry and speaks from his experience working in BC. With a landman father, Matteo was exposed to the industry early. The stories he heard from his father and father's colleagues impressed upon him the idea of landmen as problem solvers which gave him a fascination with the industry. Out of university he secured an internship program at Shell Canada and started his career in a research team exploring northern Canada, the Beaufort Sea area. His career would then lead him to Enbridge Energy and finally to Crew Energy.     Matteo defines the layers of British Columbia's regulatory system for Chad, starting with the Agricultural Land Reserve. An environmental report including soil examination, wildlife concerns, and even an archaeological assement, related to the Heritage Conservation Act, are all required. He explains the complexities of First Nations consultation as well. Matteo and Chad discuss the skills Matteo learned early in his career that assisted in working in BC, different regulation requirements in BC jurisdictions, and how to manage internal relationships within a company navigating a complex system. Matteo's insight and advice are valuable and shed light on what is needed for a successful venture in BC land. “I really could take some of the skills that I learned, particularly at, you know, the kitchen table and with communities across Canada. It's really honing in on that listening skill and making sure that you understand what the issues are and not assume what the issues are.” - Matteo Villani---Chad Hughes | CEO, Entrepreneurial Leader, Author: website |linkedinMatteo Villani | President of 3 Peaks Land & Engagement Inc: linkedin__

Digital Future Summit Series Episode 4: Privacy Commissioner Carly KindPresenters:Michael Swinson, KWMBryony Evans, KWMAustralian Privacy Commissioner Carly KindAustralian Privacy Commissioner Carly Kind discusses developments in privacy law reforms, the implications of AI and emerging technologies on privacy, and the regulatory landscape for data protection in Australia. Commissioner Kind highlights key priorities for the Office of the Australian Information Commissioner, focusing on the importance of balancing privacy protections with the benefits of innovation in the digital economy.Key points:Passing of the first tranche of privacy law reforms and new statutory tort for serious invasions of privacy – an important step for individual rights and regulatory enforcement.The OAIC's regulatory priorities: addressing persistent privacy harms, particularly in the online realm, and rebalancing power asymmetries to protect vulnerable groups.Commissioner Kind highlights the need for clarity on how existing privacy laws apply to new technologies like AI and the importance of transparency.The conversation covers development of the Children's Online Privacy Code and the need for age-appropriate consultations to ensure children's privacy protection.Commissioner Kind discusses the value of collaboration with other regulators, both domestically and internationally, to address privacy challenges particularly regarding emerging technologies like AI and facial recognition.Additional Resources here:KWM Insight | First tranche of privacy law reforms – breading down the Privacy Amendment BillKWM Insight | Statutory tort for serious invasions of privacyKWM Insight | Introduction of social media banKWM Insight | Social Media Minimum Age Bill IntroducedKWM Insight | Rebooting the system – the Government announces its plans for the Consumer Data Right

AI growth with no rules? That's not bold. It's reckless.Everyone's racing to scale AI. More data, faster tools, flashier launches.But here's what no one's saying out loud:Growth without governance doesn't make you innovative. It makes you vulnerable.Ignore ethics, and you're building an empire on quicksand.In this episode, we're breaking down how to scale AI the right way—without wrecking trust, compliance, or your future.Newsletter: Sign up for our free daily newsletterMore on this Episode: Episode PageJoin the discussion: Questions for Rajeev or Jordan? Go ask.Upcoming Episodes: Check out the upcoming Everyday AI Livestream lineupWebsite: YourEverydayAI.comEmail The Show: info@youreverydayai.comConnect with Jordan on LinkedInTopics Covered in This Episode:Balancing AI Innovation with Ethical GovernanceIntroduction of Rajeev Kapur and Eleven o Five MediaRajeev Kapur's Background in AICompanies Balancing AI Innovation and EthicsFormation of AI Ethics BoardData Management as Competitive AdvantagePrivacy and Ethics as Product FeaturesGovernance and Ethical Standards in AI UseImpact of Regulatory Changes on AI UseDeepfakes and Their ImplicationsEncouragement for Companies to Lead Ethically in AITimestamps:00:00 Navigating AI: Innovation vs. Risks04:00 "AI Startup's Spatial Audio Journey"06:49 AI Ethics Oversight & Governance10:04 Strategic AI Advisory Team Formation15:34 AI Strategy and Governance Essentials16:55 Global Standardization Needed for AI Policies22:47 AI Ethics: Innovation vs. Deepfakes25:48 "Regulate Deepfakes Like Nukes"27:17 Leadership Vision for Future SuccessKeywords:AI innovation, Ethical governance, Large language models, Data privacy, AI ethics board, AI governance, TDWI, Microsoft stack, Generative AI, AI algorithms, Spatial audio, Deep fakes, Data differentiation, Machine learning, Cyber security, Enterprise technology, Rajeev Kapur, 11:05 Media, AI safety, OpenAI, Data utilization, Ethical AI alignment, Regulatory aspect, AI models, Innovation vs. ethics, AI data privacy, Explainability, Data scientists, Third-party audits, Transparent AI usage, AI-driven growth, Monitoring feedback loops, Worst case testing, Smart regulations, Digital twins, Disinformation, AI bias mitigation, Data as new oil, Refining dataSend Everyday AI and Jordan a text message. (We can't reply back unless you leave contact info) Ready for ROI on GenAI? Go to youreverydayai.com/partner

Spencer Cibelli, Investment Associate at Robotti & Company, stops by to discuss Haypp Group; the world's largest online retailer of nicotine pouches and traditional snus products. The nicotine pouch category is, as Mugatu would say, "So hot right now." Spencer details Haypp's unique characteristics, benefit to customers, and value offered to suppliers. This business has an interesting niche. And may just be an unlikely "Win-Win-Win" example. Enjoy the episode! Sponsor NotesThis episode is brought to you by Fiscal.aiFiscal.ai is the complete modern data terminal for global equities. The Fiscal.ai platform combines a powerful user experience with all the financial data capabilities that professional investors need. Users get up to 20 years of historical financials for all stocks globally that they can easily chart, compare, or export into their own models. And unlike legacy data terminals where it can take hours or even days, Fiscal.ai's data is updated within minutes of earnings reports. Fiscal.ai also tracks all company specific Segment & KPI data so you dont have to!Use my affiliate link fiscal.ai/brew, you will automatically get 2 weeks of Fiscal Pro for Free and if you find that you want to upgrade, my link will get you 15% off any paid plans. TakeawaysHaypp is the world's largest online retailer of nicotine pouches.The company has a unique data insights business that contributes to its revenue.Consumer behavior in the nicotine pouch market shows a willingness to switch brands.Regulatory challenges are significant but manageable for Hape.Pricing strategies allow Haypp to offer lower prices than traditional retailers.The growth potential in the nicotine pouch market is substantial, especially in the US.Management's long-term vision is focused on market share growth.Valuation metrics suggest Haypp is an attractive investment opportunity.The online penetration of nicotine products is still low, indicating room for growth.Haypp's relationships with manufacturers are symbiotic and beneficial for both parties.

Interview with Rafael Moreno, Managing Director & CEO of Viridis Mining & MineralsRecording date: 2nd Sept 2025Viridis Mining & Minerals (ASX:VMM) is advancing the Colossus ionic clay rare earth project in Brazil's Minas Gerais state, focused on producing high-value rare earth elements neodymium, praseodymium, dysprosium, and terbium (NdPr-DyTb) with very low radioactive content. The project benefits from simple free-dig mining of shallow deposits and straightforward atmospheric-pressure processing, enabled by a unique ionic clay geological formation. These factors contribute to superior economics, with a pre-feasibility study (PFS) estimating a net present value (NPV) of US$1.41 billion and annual operating cash flow around US$200 million at current rare earth prices.Colossus's grades are 4 to 6 times higher than comparable Chinese projects, supporting competitive costs even at lower commodity prices. Regulatory advantages include a radiological exemption from Brazil's nuclear regulator, which keeps environmental approvals at the state level rather than federal, accelerating permitting timelines from years to weeks. The project also features strong environmental credentials, with 100% renewable power, 75% water recycling, and immediate site rehabilitation.Financing momentum is strong, with up to US$30 million committed from leading Brazilian asset managers and ongoing discussions with Brazil's development bank BNDES. Offtake talks span Brazil, Europe, and North America, positioning Colossus as a globally relevant supply source. Near-term milestones include imminent environmental approval, a demonstration plant operational by Q1 2026, mineral resource updates by mid-2026, and a definitive feasibility study (DFS) by June 2026.Led by CEO Rafael Moreno, with deep project execution experience, Viridis is developing Colossus to meet growing global demand driven by electric vehicles, renewable energy, and supply chain diversification concerns. The project's combination of high-grade ore, regulatory fast-tracking, operational simplicity, and sustainable practices create a compelling investment thesis for establishing a non-Chinese rare earth supply focused on permanent magnets, with a potential 60-year mine life ensuring long-term value and market resilience.View Viridis Mining & Minerals' company profile: https://www.cruxinvestor.com/companies/viridis-metals-miningSign up for Crux Investor: https://cruxinvestor.com

Lindsay Mateo is the Chief Commercial Officer at Weave. This company has developed a platform to automate and streamline the regulatory documentation process for FDA submission for pharmaceutical and biotech companies.  The regulatory lifecycle for drug development currently involves data from various sources in digital and paper formats. Weave Bio's tools are designed to automate and streamline administrative aspects of the regulatory process and create a living digital record of the development of the drug, which supports collaboration and saves time. Lindsay explains, "I look at the regulatory life cycle for any given drug program, and experts are at the core of that. Those experts, who are scientists, strategists, and project managers, essentially put all the work into the documentation that goes to regulators like the FDA here in the US. And that information goes on to allow this drug to continue through various stages of development to ultimately get to market and obviously help patients." "That is everything from early studies looking at how drugs are being handled in animals, in mice and rats, all the way through to clinical development. We start to get into humans and then again out through what gets drugs to market and even post-market expansion of various labels. So this is critical to getting any therapy to any patient with any condition. The process itself, the challenge with the process is that it's manual."  #Weave #WeaveBio #Pharma #Biopharma #WeavePlatform #AINative #AutoCT #AutoND #FDASubmission #RegulatoryDocumentation Weave.bio Listen to the podcast here  

Lindsay Mateo is the Chief Commercial Officer at Weave. This company has developed a platform to automate and streamline the regulatory documentation process for FDA submission for pharmaceutical and biotech companies.  The regulatory lifecycle for drug development currently involves data from various sources in digital and paper formats. Weave Bio's tools are designed to automate and streamline administrative aspects of the regulatory process and create a living digital record of the development of the drug, which supports collaboration and saves time. Lindsay explains, "I look at the regulatory life cycle for any given drug program, and experts are at the core of that. Those experts, who are scientists, strategists, and project managers, essentially put all the work into the documentation that goes to regulators like the FDA here in the US. And that information goes on to allow this drug to continue through various stages of development to ultimately get to market and obviously help patients." "That is everything from early studies looking at how drugs are being handled in animals, in mice and rats, all the way through to clinical development. We start to get into humans and then again out through what gets drugs to market and even post-market expansion of various labels. So this is critical to getting any therapy to any patient with any condition. The process itself, the challenge with the process is that it's manual."  #Weave #WeaveBio #Pharma #Biopharma #WeavePlatform #AINative #AutoCT #AutoND #FDASubmission #RegulatoryDocumentation Weave.bio Download the transcript here  

Stablecoins, backed by currencies or government bonds, are enabling low-cost, cross-border transactions and expanding financial access globally. Their adoption is accelerating due to new legislation, with significant use in high-inflation countries. Experts identify risks including dollarization, capital flow volatility, weakened banking systems, and increased financial crime. Regulatory frameworks have not kept pace with innovation, as nonbank firms and AI-driven lenders reshape financial services. Governments and central banks are introducing fast payment systems, such as India's Unified Payments Interface, to compete with private sector innovation. Authorities are focusing on balancing innovation, consumer protection, and crime prevention as stablecoins and digital assets become more prominent in global finance.Learn more on this news by visiting us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.

Medboard   EUROPE Guidance on the implementation of the Master UDI-DI - MDCG 2024-14 - rev.1 : https://health.ec.europa.eu/document/download/c8c6cca5-460e-410e-a325-be08bfc7dea6_en?filename=mdcg_2024-14_en.pdf Updated - Notified bodies survey on certificates under MDR and IVDR: https://health.ec.europa.eu/document/download/59b9d90e-be42-4895-9f6f-bec35138bb0a_en?filename=md_nb_survey_certifications_applications_en.pdf There's a significant backlog: far more applications submitted than certificates issued, especially for IVDs. Time for certification: between 13 to 18 months on average Delay due to application missing critical information and refusal due to submission outside NB scope No transparency on capacity Germany new radiation protection regulation - Start July 1st, 2025: https://www.bfarm.de/DE/Arzneimittel/Klinische-Pruefung/Strahlenschutz/_artikel.html?nn=986770If device emit radiation and need clinical investigation in germany: Include a radiation risk assessment in your clinical investigation dossier Coordinate with Radiation protection authorities Update investigator brochure and patient information Stricter Monitoring & Reporting Impact on Timelines So stricter documentation, more authorities involved and longer approval times   UK MHRA launches Route B notification pilot Clinical trials regulations rollout: https://www.gov.uk/government/news/mhra-launches-route-b-notification-pilot-as-part-of-clinical-trials-regulations-rollout  -  https://www.gov.uk/guidance/notify-mhra-about-a-clinical-investigation-for-a-medical-device   Switzerland New in Swissdamed - Medical Device registration with UDI Device Module: https://www.swissmedic.ch/swissmedic/en/home/medical-devices/medizinprodukte-datenbank/swissdamed-informationen/registrierung-mepprodukte-moeglich.html 1 july-2026   Magazine Easy Medical Device Mag - Your QA RA Magazine: https://mailchi.mp/easymedicaldevice/emdmag1   Podcast: Best 40 Medical Device Podcast - Thanks: https://www.millionpodcasts.com/Medical-Device-podcasts/   REST OF THE WORLD SaMD and/or Artificial Intelligence on the spotlight - All countries want their regulation on it:  USA: PCCP - https://www.fda.gov/regulatory-information/search-fda-guidance-documents/marketing-submission-recommendations-predetermined-change-control-plan-artificial-intelligence SFDA: Workshop September 9th: https://www.sfda.gov.sa/en/workshop/4387139 TGA: Understanding regulation of software-based medical devices: https://www.tga.gov.au/resources/guidance/understanding-regulation-software-based-medical-devices#samd-and-ai-medical-device-compliance SAHPRA: Regulatory Requirements of AI/ML: https://www.sahpra.org.za/document/regulatory-requirements-of-artificial-intelligence-and-machine-learning-ai-ml-enabled-medical-devices/ Medical Device or Wellness device - Choose your side: https://www.sfda.gov.sa/sites/default/files/2025-08/MDS-G027.pdf  

Canada’s seed regulatory framework has been the focus of the Canadian Food Inspection Agency's (CFIA) seed regulatory modernization (SRM) review for the past several years. The system is overdue for an overhaul, but the SRM proposal document from the CFIA up for discussion falls well-short of delivering real change, according to Laurin Comin, director of... Read More

HTT – Thu Sep 4, 2025 Welcome to Hashtag Trending! I'm your host, Jim Love. Today's episode explores the shifting landscape of jobs in the age of AI, the global response to AI-generated content, and the financial realities of the ongoing AI boom. We raise more questions than answers, diving into the stories shaping our tech future. In this episode: The US faces a shortage of 2.1 million manufacturing workers by 2030, with automation creating new roles faster than workers can be trained. The impact of AI on white-collar jobs, with up to a third of banking and financial services tasks at risk of automation. China's crackdown on “AI slop” with mandatory labeling of AI-generated content, and how Western platforms are responding. Switzerland launches Apertus, a fully transparent, open-source large language model, setting a new standard for AI transparency and ethics. The AI investment paradox: billions are being poured into AI, but are the business models sustainable? We look at the financials of tech giants and the risks of the current AI gold rush. Apple's cautious approach to AI and why it might pay off in the long run. Key Takeaways: Automation is transforming, not just replacing, jobs—demanding new skills and training. Regulatory approaches to AI content are diverging globally. The business of AI is booming, but profitability and sustainability remain open questions. Connect with us: Share your thoughts in the comments below! Reach out at technewsday.ca or .com (Contact Us page) Listen on Apple, Spotify, YouTube, and more. If you enjoyed the show, please like, comment, and share! AI #Automation #TechNews #Jobs #China #Switzerland #Apple #Podcast

Partner Geoff Petersen joins us fresh from the ACCC/AER Regulatory Conference with the latest on regulating infrastructure, the energy transition, competition and innovation. Plus the Government's Economic Reform Roundtable; a second leasehold on the ACCC's acquisitions register earns a new frequently asked question; more casualties at the US antitrust agencies; and what even is a notification waiver? All this and Sudanese cinema with co-hosts Moya Dodd and Matt Rubinstein of The Competitive Edge podcast. [Links] Breaking news: Treasury has released its draft Notification Waiver form for consultation. G+T's analysis compares the draft form to the short-form notification form. Allegedly former FTC Commissioner Rebecca Slaughter is back at work for now after the DC Circuit Court of Appeals found 2-1 that the administration had no likelihood of success. Links: The first episode of "Conference 27" on YouTube Khartoum Offside on Kanopy G+T on Lease Agreements on the Acquisitions Register We've all been saying "Passiona" wrong Former Principal Deputy Assistant Attorney General Roger Alford on the DOJ and the HP-Juniper merger Product placement in the Top Gun movies G+T on safeguarding our energy supply Meet the Gilbert + Tobin Competition, Consumer + Market Regulation team Email us at edge@gtlaw.com.au Support the show: https://www.gtlaw.com.au/See omnystudio.com/listener for privacy information.

In this episode of Medsider Radio, we sat down with Christopher Haig, co-founder and CEO of Efemoral Medical. Efemoral is developing bioresorbable scaffold technology for peripheral arterial disease. Chris has over 25 years of experience in cardiovascular devices, holding leadership roles at strategics including Guidant Corporation and Abbott Vascular, and driving growth at startups such as Calypso Medical and QT Vascular, where he built commercial infrastructure and launched multiple products ahead of its $55 million IPO.In this interview, Chris shares how bioresorbable scaffold technology found new life for peripheral arterial disease — and the lessons on matching tech to significant needs and choosing trial sites for lasting data.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Christopher Haig.

World Liberty Financial's token "WLFI" began listing on several crypto exchanges this week. The biggest holder of WLFI? The Trump family. Jenny Horne and Adam Lynch look into the latest crypto trends this week, including an update from the SEC & CFTC. Plus, Jenny and Adam look at historical performance trends for Bitcoin as the month of September begins.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

iGaming Daily's Road to Lisbon continues, as SBC Media Manager Charlie Horner is joined by Vlad Kaltenieks, CEO of Boyle Sports, to discuss bold investment plans, the future of retail betting, high-profile football sponsorships, and how the operator is preparing for fresh regulatory and tax challenges.Tune in to find out:Why Boyle Sports is betting big on UK & Ireland despite heavy regulation and market uncertaintyThe surprising reasons retail shops remain central to their growth strategyInside their headline West Ham sponsorship deal and what it means in a post-FoS eraHow Boyle Sports is bracing for tax hikes and fresh regulatory pressure across EuropeHow the industry can tackle the black market.Join Vlad at SBC Summit Lisbon for the panel: EUROPEAN LEADERS PANEL: Old World, new way forward - how the most established brands are rethinking regulation and retention: Could a tighter regulatory landscape stifle innovation? How can operators communicate effectively with regulators, win the court of public opinion, and retain their lucrative customer bases in an increasingly global gambling arena?Host: Charlie HornerGuest: Vlad KaltenieksProducer: Anaya McDonaldEditor: Anaya McDonaldiGaming Daily is also now on TikTok. Make sure to follow us at iGaming Daily Podcast (@igaming_daily_podcast) | TikTok for bite-size clips from your favourite podcast.Finally, remember to check out Optimove at https://hubs.la/Q02gLC5L0 or go to Optimove.com/sbc to get your first month free when buying the industry's leading customer-loyalty service.

Relational Healing, Neuroplasticity, and the Power of Psychedelic-Assisted Therapy: An Interview with Dr. Alexa Altman, Ph.D. and Shira Myrow, LMFT In this episode, Curt and Katie chat with Dr. Alexa Altman and Shira Myrow, LMFT, about psychedelic-assisted therapy and how it supports trauma healing, neuroplasticity, and relational transformation. They explore how these treatments work, what integration really means, and how therapists can ethically and safely engage with this emerging field. About our guests:Dr. Alexa Altman and Shira Myrow, MFT, are co-founders of iPsychedelic Therapy. With backgrounds in trauma-informed psychology, spiritual counseling, and relational healing, they offer a holistic approach to psychedelic-assisted therapy that centers ethical care, integration, and transformational growth. Key takeaways: Psychedelics are not shortcuts—they act as amplifiers and accelerants in trauma work. Integration is a crucial part of psychedelic-assisted therapy and often overlooked. Clinicians must examine their own biases and seek robust training. Some clients are not appropriate for these treatments due to fragility or lack of therapeutic background. A safe therapeutic container, rigorous consent, and preparation are essential. Regulatory frameworks are still emerging and need clinician involvement. More info, transcripts, and full show notes: mtsgpodcast.com Join the Modern Therapist Community: Linktree Creative Credits: Voice Over by DW McCann Music by Crystal Grooms Mangano

Christos Efthymiopoulos of the Bermuda Monetary Authority joins Solidus Labs' Delphine Forma to discuss Bermuda's pioneering approach to digital asset regulation, sandbox licensing, market integrity, AML/CFT, and the future of DeFi supervision.

In this episode, the hosts analyze a Colorado gun range and retail shop listed at $2M, diving into regulatory risks, slim margins, and whether the business is worth its heavy inventory investment.Business Listing – https://www.tworld.com/agents/charleymitchell/listings/turnkey-and-established-gun-range-and-shopWelcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.

Moment Energy is transforming the energy storage landscape by giving electric vehicle batteries a second life. With $32 million in government grants secured and a 2-gigawatt-hour facility under construction in Austin, Texas, the company is pioneering the repurposing of end-of-life EV batteries into stationary energy storage systems. In this episode of Category Visionaries, I sat down with Edward Chiang, Co-Founder and CEO of Moment Energy, to explore how his team is solving the dual challenges of EV battery waste and distributed energy storage while building a commercially viable hardware business. Topics Discussed: The $4,000 recycling cost problem facing EV owners at end-of-life How 80-95% capacity remains in "dead" EV batteries due to single cell failures Moment Energy's vision for distributed energy storage at every neighborhood block The certification maze: becoming the first North American company to achieve UL 1974 Securing $32M in government contracts from the DOE and Canadian government Commercial-industrial customer strategy targeting Fortune 500 companies The unique challenges of hardware go-to-market versus SaaS   GTM Lessons For B2B Founders: Sell on economics, not sustainability: Despite the environmental benefits of battery repurposing, Chiang emphasizes selling purely on cost and performance metrics. He explained, "We never sell based on sustainability... We just sell on typical cost and power." B2B founders should resist leading with feel-good messaging and instead focus on measurable business outcomes that matter to their buyers' bottom line. Target infrastructure decision-makers, not sustainability teams: Moment Energy focuses on buyers who "manage the energy infrastructure for the entire [organization]" because "there's a lot less education that's required. They know how to speak batteries." While sustainability teams can provide useful introductions, the real decision-makers understand the technical and economic trade-offs. B2B founders should identify the specific roles that truly own their problem space rather than getting distracted by adjacent stakeholders. Regulatory barriers become competitive moats: The extensive certification process that costs hundreds of thousands of dollars in burn testing creates what Chiang calls "a massive barrier to entry for any incumbents to come in." While painful initially, these regulatory requirements can provide sustained competitive advantages. B2B founders in regulated industries should view compliance costs as investments in defensibility rather than just operational expenses. Government contracts require commercial proof points: Chiang noted that government agencies "want to make sure that you're actually commercially ready rather than just a big marketing play." They validate systems in the field and measure actual impact before awarding contracts. B2B founders pursuing government opportunities should prioritize demonstrable commercial traction over grant-writing skills, as real customer deployments become the foundation for larger contracts. Hardware requires deeper customer conviction: Unlike software pilots, Chiang explains that their systems "cannot go down because it's not a pilot" and customers need complete confidence from day one. This means hardware founders must achieve higher customer conviction thresholds before securing deals. The extended sales cycles and higher stakes require more thorough technical validation and risk mitigation than typical SaaS implementations.   //   Sponsors: Front Lines — We help B2B tech companies launch, manage, and grow podcasts that drive demand, awareness, and thought leadership. www.FrontLines.io The Global Talent Co. — We help tech startups find, vet, hire, pay, and retain amazing marketing talent that costs 50-70% less than the US & Europe.  www.GlobalTalent.co   //   Don't Miss: New Podcast Series — How I Hire Senior GTM leaders share the tactical hiring frameworks they use to build winning revenue teams. Hosted by Andy Mowat, who scaled 4 unicorns from $10M to $100M+ ARR and launched Whispered to help executives find their next role. Subscribe here: https://open.spotify.com/show/53yCHlPfLSMFimtv0riPyM 

In this episode, the hosts analyze a Colorado gun range and retail shop listed at $2M, diving into regulatory risks, slim margins, and whether the business is worth its heavy inventory investment.Business Listing – https://www.tworld.com/agents/charleymitchell/listings/turnkey-and-established-gun-range-and-shopWelcome to Acquisitions Anonymous – the #1 podcast for small business M&A. Every week, we break down businesses for sale and talk about buying, operating, and growing them.

This episode features Cereasa Horner, Director of Policy and Payment Integrity at CERIS, who shares insights on the evolving payer oversight landscape. She discusses the challenges of maintaining consistency across state and federal guidelines, the role of AI and predictive compliance modeling, and strategies for payers to stay proactive in a dynamic regulatory environment.This episode is sponsored by CERIS.

In this episode of The Consumer Finance Podcast, Chris Willis, Heryka Knoespel, and Lori Sommerfield discuss overdraft and deposit account fees as they continue to dive into the CFPB's guidance withdrawal. They highlight the regulatory and litigation impacts of the rescinded guidance and its impact on banks and financial institutions, particularly in terms of compliance burdens and fee income, while also weighing potential reputational risks and operational challenges that may arise if policy changes follow the CFPB's withdrawn guidance. This episode also emphasizes the importance of financial institutions being prepared to defend against lawsuits, specifically those related to Regulation E and affirmative consent.

In this episode of Medsider Radio, we sat down with Howard Rosen, co-Founder and CEO of Evident Vascular, a company developing an AI-powered intravascular ultrasound (IVUS) platform to improve vascular imaging and intervention. Before co-founding Evident, Howard held senior leadership roles at Intact Vascular and Vesper Medical, guiding both companies through successful acquisitions by Philips. He also served in executive roles at Haemonetics and BG Medicine, and spent over two decades at Boston Scientific, where he held a range of leadership positions across the peripheral and cardiovascular franchises.In this interview, Howard shares why launching right — not fast — is the key to success in medtech. He breaks down how Evident built early momentum by investing in deep market validation, engaging KOLs as true collaborators, and resisting scope creep at every turn. Howard also unpacks the company's deliberate regulatory strategy, using early FDA engagement as a tool to de-risk development. On the fundraising front, he explains why board composition matters more than valuation, and why strategic acquirers respond best to credibility, not cold outreach.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Howard Rosen.

The Joint Commission's updated accreditation manual is designed to simplify requirements, enhance clarity, and better support healthcare organizations in survey preparation. In this episode of VerifiedRx, host Carolyn Liptak is joined by Dr. Robert Campbell of the Joint Commission and Diana Scott of Vizient to unpack the most significant changes. From the shift to National Performance Goals and medication safety priorities to the latest challenges in compounding, labeling, and hazardous drug handling, the conversation highlights practical insights to help pharmacy leaders stay compliant and survey-ready.   Guest speakers: Robert Campbell, PharmD, BCSCP Sr. Director, Standards Interpretation, Accreditation Decision Management,Medication Safety Division of Accreditation and Certification Operations Joint Commission   Diana Scott, MHA, RN, CPHQ Principal, Regulatory and Accreditation Services Vizient   Host:  Carolyn Liptak, , BS Pharm, MBA   Vizient   Show Notes:  [01:16-01:51] Diana and Robert Backgrounds [01:52-02:43] Changes made to the hospital and critical access hospital manuals [02:44-03:09] Changes to the chapters themselves [03:10-04:08] National Performance Goals and elaborate on those that are relevant to medication safety and pharmacy services [04:09-05:15] The top medication management challenges [05:16-06:29] Pain management not being aligned and titration orders [06:30-06:56] Insufficient communication between pharmacists, prescribers and nurses when it comes to medication orders [06:57-08:02] Themes around labeling requirements for stored medications [08:03-08:46] Anything different in removing expired meds from patient care areas and in the pharmacy this area than previous years [08:47-10:58] Issues related to storing meds specifically per the package insert [10:59-11:55] Common issues seen inside the pharmacy regarding sterile compounding, noncompliance include hand hygiene, garbing, PPE, and cleaning and disinfecting [11:56-13:12] More specifics in those area the physical environment and facility cleanliness along with cleaning and disinfection practices [13:13-14:55] Explaination of how joint Commission defines and evaluates immediate use compounding [14:56-16:09] The minimum required elements for immediate use compounding competency [16:10-17:12] Compounding competencies besides immediate use [17:13-17:54] Expectations for environmental services training [17:55- 20:14] Concerns around hazardous drugs [20:15- 21:14] Additional information   Links | Resources: Joint Commission: THE NEW STANDARD: Accreditation 360   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed

Jeffrey Collins, Managing Partner of Cloverlay, stops by to discuss how Cloverlay builds private portfolios to offer clients uncorrelated returns. In this conversation, Jeff explains how Cloverlay provides access to private assets that are often overlooked by traditional investors, emphasizing the importance of correlation in portfolio management. The discussion covers various investment opportunities, including sports rights, telecom spectrum auctions, dark fiber, and intellectual property. Jeff shares insights on navigating regulatory changes and lessons learned from past investments, ultimately highlighting the future outlook for investment strategies in a rapidly evolving market.TakeawaysCloverlay specializes in esoteric niche private assets.The firm manages $1.6 billion in assets.Investments are designed to be uncorrelated and predictable.Understanding correlations is key to portfolio management.Investing in sports rights was a unique opportunity in 2020.Telecom spectrum auctions favor smaller investors.Dark fiber investments are critical for data centers.Regulatory changes can create new investment opportunities.Past investments provide valuable lessons for future strategies.Cloverlay aims to be a resource for institutional investors. Jeff's BioJeff serves as Managing Partner of Cloverlay and is a member of the Firm's Investment Committee and Board of Directors. Prior to founding Cloverlay, Jeff was a Managing Director with Morgan Stanley Alternative Investment Partners (AIP), a division of Morgan Stanley's institutional asset management business. While at AIP, Jeff was a member of the Executive and Business Committees and served on AIP's Private Markets Investment Committee as a Portfolio Manager responsible for leading primary fund, co-investment and secondary transactions focused on special situations globally and North American buyouts. Prior to AIP, Jeff advised and traded equity options and futures with U.S. hedge funds in Morgan Stanley's Equity Derivatives Group in New York. Prior to Morgan Stanley, Jeff was on the investment team at Petra Capital Partners, where he was responsible for screening, researching, structuring and monitoring private equity investments in health care and information services companies. Prior to Petra Capital, Jeff was an investment banker at Robertson Stephens, where he executed a variety of public and private equity, debt and convertible offerings along with mergers and acquisitions in financial services, health care, and business services.

The Unified Program Integrity Contractors (UPICs) are household names in healthcare compliance.But their track record tells a troubling story, according to senior healthcare analyst Frank Cohen. These Medicare fraud enforcement contractors are using controversial extrapolation techniques that providers successfully challenge over 60 percent of the time on appeal.Cohen, who will be the special guest during the next live edition of Monitor Mondays, said he will examine how the 2016 consolidation created five regional enforcement powerhouses, along with why their statistical methodologies are devastating practices based on flawed assumptions. Cohen intends to show how misaligned incentives are creating systematic accuracy problems, while revealing why the current UPIC system might be fundamentally broken, despite everyone agreeing that fraud prevention matters.The weekly broadcast will also include these instantly recognizable features:• Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.• The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.• Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.• Legislative Update: Matthew Albright, chief legislative affairs analyst for Zelis, will report on the news happening at the intersection of healthcare and congressional action.

In this episode, we delve into the critical importance of financial independence and the role skepticism plays in achieving it. Join us as we explore strategies for building a secure financial future and discuss how questioning conventional wisdom can lead to smarter financial decisions. Whether you're just starting your financial journey or looking to refine your approach, this conversation offers valuable insights and practical advice. Tune in to empower your financial mindset!

At the EUVC Summit 2025, Kerry Baldwin (IQ Capital) and Chris Elphick led one of the most urgent conversations of the year:Can Europe mobilize its pension capital to fund innovation—or will it stay stuck on the sidelines?With £1 trillion expected to be funneled into innovation, growth, and venture by 2030, the opportunity is massive. But unlocking it will take more than speeches and slogans. It will take structures, translation, and a whole lot of education.Chris opened by setting the context:In July 2023, 10 of the UK's largest pension funds agreed to invest 5% of assets into unlisted equities—representing £5 billion of fresh capital.That capital is (unsurprisingly) biased toward private equity. But the real win?Getting a meaningful slice of it into venture.We now have the technical tools to do it:The introduction of Long-Term Asset Funds (LTAFs)—with 27 launched to date—means the legal infrastructure is in place.Regulatory shifts have opened the door. Now it's time to walk through it.“The pipes are built. Now we need to make the case.”As Kerry pointed out, it's not just about access—it's about alignment.“The pension world doesn't speak venture. It speaks in valuations, risk ratings, board approvals, and actuarial models.”To bridge the gap:Ditch the pitch decks. Instead, build relationships.Use case studies. Show, don't just tell.Speak their language. Get founders in the room. Educate through stories and real-world examples.And yes, explain your fees—transparently.→ “We charge fees because we hunt. We engage with professors. We run deep knowledge sessions. That's where the value lives.”Kerry closed with a critical reminder from someone who's seen the cycles before—2001, 2009, and now:“Just play nicely.”→ That means fair terms.→ Respecting early-stage angels.→ Not forcing founder-unfriendly clauses when capital is tight.Venture doesn't work when trust is broken at the seed layer.The prize is on the table. The pipes are laid. The policymakers are listening.Now it's up to us—as GPs, founders, LPs, and ecosystem builders—to:Make venture legibleBuild long-term trustAnd design financial vehicles that serve founders, fuel returns, and unlock national innovation agendas“Let's stop waiting for the future to finance itself. Let's build the financial architecture to fund it now.”The Landscape: Shifting Regulations, Real PotentialThe Real Bottleneck? Language & UnderstandingA Word of Warning: Don't Harm the EcosystemA Trillion-Pound Opportunity—If We Get This Right

Hosts Karl Schmieder and Erum Azeez sit down with Dr. Kyle Landry, President and Co-founder of Delavie Sciences, to explore how extremophiles—microbes that survive in the harshest environments on Earth and space—are unlocking new frontiers in skincare and longevity. Kyle shares his unconventional path from food science to biodefense to NASA collaborations, revealing how a microbe that survived 18 months outside the International Space Station became the foundation for a groundbreaking sunscreen ingredient. The conversation dives into longevity science, microbial resilience, the future of skincare as true preventative health, and the entrepreneurial challenge of scaling biotech innovations from test tube to industrial reactors.Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing?Links and Resources:Chris Mason Episode Kate Rubins Episode Erika DeBenedictis EpisodeLifespan.ioFight Aging! Delavie Sciences David Sinclair's Novel - Lifespan: Why We Age and Why We Don't Have To Efficacy of a Novel SPF Booster Based on Research Aboard the International Space StationNASA iTECHChapters:(00:00:00) - Introduction to the episode and the Grow Everything podcast(00:00:49) - Aging by Biotech NYC event overview(00:03:35) - Tips on being a great moderator(00:04:03) - Keys to moderating well: preparation and audience engagement(00:07:20) - Notable absence of space topics at longevity event(00:09:40) - Guest introduction: Dr. Kyle Landry and his background(00:10:13) - Story of how the hosts met Kyle Landry(00:11:42) - Career journey from food science to skincare(00:14:27) - Inspiration from space research leading to Delavie Sciences(00:17:25) - How Delavie's product works at a molecular level for sun protection and anti-aging(00:20:43) - Evolution of the space microbe and cultivation on Earth(00:22:31) - What it means for a microbe to “sit outside the space station”(00:23:26) - Professional connections with other Grow Everything guests, Chris Mason and Dr. Kate Rubins(00:24:29) - Potential for Delavie to expand beyond skincare into new industries(00:26:11) - Lessons from researching extremophiles and challenges of working with new organisms(00:28:22) - Role in mentoring students and researchers(00:31:36) - Rethinking health and resilience in biotechnology(00:33:20) - Exploring the “product versus platform” dilemma in biotech entrepreneurship(00:34:48) - How Delavie functions as both a technology platform and a product company(00:36:29) - Corporate partnerships and product applications of Delavie's ingredients(00:38:53) - Clarification: using microbial compounds, not live bacteria, in products(00:39:59) - Importance of protecting the skin microbiome without disrupting it(00:42:46) - The future of skincare and longevity(00:45:03) - Quick-fire questions begin(00:45:19) - Weirdest place to hunt for a microbe(00:45:31) - Bio-fact most people don't believe but should(00:46:48) - Personal skincare non-negotiable(00:48:20) - Would you rather halt or reverse aging?(00:48:51) - Weirdest place a sample has been collected(00:51:14) - Post-interview reflections and discussion(00:52:54) - Takeaways from the interview and the concept of convergence(00:54:03) - Conversation on Umami flavor and UV light spectrums(00:56:00) - Regulatory differences in sunscreen between the US and Europe(00:58:14) - Announcement of the BioFabricate Fair and listener discount codeTopics Covered: biotech beauty, space biotech, skin care, biomanufacturing, longevity, extremophiles  Have a question or comment? Message us here:Text or Call (804) 505-5553Instagram  / Twitter / LinkedIn / Youtube / Grow Everything

Jeremiah Mosteller, attorney and policy director at Americans for Prosperity, joins the conversation to explain why Congress should follow up tax reform with meaningful regulatory relief. He points to the success of the One Big Beautiful Bill Act's tax reforms as a strong first step, but stresses that real, lasting prosperity requires reducing the regulatory burdens that stifle innovation, business growth, and opportunity for everyday Americans.

In this episode of Medsider Radio, we sat down withTracy MacNeal, President and CEO of Materna Medical. Materna is developing two devices addressing different aspects of pelvic health: Ellora, aimed at preventing childbirth injuries during delivery, and Milli, designed to treat vaginismus, a pelvic floor condition that makes intercourse painful or impossible.Tracy is a healthcare executive and engineer with over 25 years of experience in medical devices, digital health, and women's health, including six successful transactions. In addition to heading Materna, Tracy serves on the AdvaMed Board and leads its Women's Health Equity Initiative, and was previously President of Diagnostics and Digital Health at Ximedica.In this interview, Tracy shares how clinical data enabled Materna to bridge B2B and B2C channels, and why clarity of focus is essential when commercialization paths diverge. Tracy also outlines what it takes to build in undefined markets, from aligning KOLs to publishing foundational definitions, and offers a candid perspective on what investors really want: clear financial returns, backed by a founder they trust to deliver when things go sideways.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Tracy MacNeal.

Summary Nel nuovo episodio del nostro podcast, parliamo di un tema spesso percepito come tecnico e complesso, ma in realtà sempre più strategico: il mondo del Regulatory nei rivestimenti industriali. Ne discutiamo con Alice Paiotta, Regulatory & Quality Assurance Manager Europe in Carboline, che ci guida in un viaggio tra REACH, sostenibilità, rischi normativi, competitività e innovazione. Timestamps 00:53 – Introduzione 01:16 – Presentazione dell'ospite: Alice Paiotta 02:03 – Che cos'è il regulatory in un'azienda che produce rivestimenti e prodotti antincendio 02:40 – I principali regolamenti applicabili in Europa 03:34 – Focus sul Regolamento REACH 04:21 – Le autorità competenti in Europa per il settore dei rivestimenti 05:44 – Come è evoluta la regolamentazione negli ultimi decenni 08:22 – Codice UFI: di cosa si tratta e a cosa serve 08:53 – Il futuro del regulatory secondo Alice 10:46 – L'aggiornamento delle liste di sostanze: un processo continuo 11:14 – Regolamenti europei e sostenibilità: sempre più interconnessi 13:33 – Le conseguenze della non conformità normativa (legali, economiche, reputazionali) 16:20 – Come assicurarci di non commercializzare prodotti non conformi 19:25 – Regulatory come vantaggio competitivo: quando la conformità diventa strategia 22:50 – Le principali sfide da affrontare per restare conformi 24:48 – Il percorso di Alice: dalla chimica al regulatory 28:02 – Domande extra per chiudere in leggerezza

Our friend, physicist and economist Erald Kolasi, stops by the Macro N Cheese clubhouse to talk with Steve about the profound effects of AI on the energy grid, water resources, and societal infrastructure. The discussion focuses primarily on large-scale corporate AI, such as generative AI. Erald's work bridges physics, economics, and ecology, revealing how AI's rapid expansion is not just a technological phenomenon but a biophysical crisis – one that's easy to overlook. Cloud is such a gentle word. Diaphanous. It sounds harmless. Lovely, even.“When you're in front of your computer and you're just typing away and you're asking these systems to do all these magical things for you, it can seem like it comes out of nowhere. But no, in reality, all of this stuff takes enormous energy.” AI's dematerialized facade obscures its physical infrastructure. It's a classic capitalist contradiction where "progress" accelerates ecological breakdown. Erald and Steve talk about the race to the bottom, as states and municipalities trade public health for tax revenue. Regulatory enforcement is absent. While exploiting labor and plundering nature, the costs are socialized as these companies use public water and energy grids. Elon Musk's xAI Colossus is based in Tennessee. (Remember the TVA, that impressive example of depression-era federal works? Help yourself, Elon.) It's not just that they use public water and energy, it's the vast and growing amounts of these resources, as Erald explains. The conversation also touches on the AI arms race, as the US competes with China, using “national security” as an excuse to justify resource wars. From energy consumption to water depletion, from labor displacement to geopolitical tensions, this episode exposes the contradictions of AI under a system that prioritizes profit over sustainability. Erald Kolasi is a writer and researcher focusing on the nexus between energy, technology, economics, complex systems, and ecological dynamics. His book, The Physics of Capitalism, came out from Monthly Review Press in February 2025. He received his PhD in Physics from George Mason University in 2016. You can find out more about Erald and his work at his website, www.eraldkolasi.com. Subscribe to his Substack: https://substack.com/@technodynamics